- Home
- RERE vs ZVRA Comparison
RERE vs ZVRA Comparison
Compare RERE & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RERE
- ZVRA
- Stock Information
- Founded
- RERE 2011
- ZVRA 2006
- Country
- RERE China
- ZVRA United States
- Employees
- RERE N/A
- ZVRA N/A
- Industry
- RERE Other Specialty Stores
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- RERE Consumer Discretionary
- ZVRA Health Care
- Exchange
- RERE Nasdaq
- ZVRA Nasdaq
- Market Cap
- RERE 444.1M
- ZVRA 400.8M
- IPO Year
- RERE 2021
- ZVRA 2015
- Fundamental
- Price
- RERE $2.58
- ZVRA $8.55
- Analyst Decision
- RERE
- ZVRA Strong Buy
- Analyst Count
- RERE 0
- ZVRA 8
- Target Price
- RERE N/A
- ZVRA $22.29
- AVG Volume (30 Days)
- RERE 847.7K
- ZVRA 608.4K
- Earning Date
- RERE 05-20-2025
- ZVRA 05-13-2025
- Dividend Yield
- RERE N/A
- ZVRA N/A
- EPS Growth
- RERE N/A
- ZVRA N/A
- EPS
- RERE 0.07
- ZVRA N/A
- Revenue
- RERE $2,388,301,386.00
- ZVRA $40,588,000.00
- Revenue This Year
- RERE $29.57
- ZVRA $276.77
- Revenue Next Year
- RERE $24.43
- ZVRA $86.15
- P/E Ratio
- RERE $35.61
- ZVRA N/A
- Revenue Growth
- RERE 26.09
- ZVRA 46.47
- 52 Week Low
- RERE $2.00
- ZVRA $4.20
- 52 Week High
- RERE $3.70
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- RERE 48.53
- ZVRA 59.19
- Support Level
- RERE $2.45
- ZVRA $8.21
- Resistance Level
- RERE $2.95
- ZVRA $8.78
- Average True Range (ATR)
- RERE 0.15
- ZVRA 0.37
- MACD
- RERE -0.01
- ZVRA 0.00
- Stochastic Oscillator
- RERE 25.00
- ZVRA 71.60
About RERE ATRenew Inc.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.